BDCL Stock UPDATES 2X Wells Fargo Bus Dv Cm ETN UBS E-Tracs (BDCL)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
2X Wells Fargo Bus Dv Cm ETN UBS E-Tracs (BDCL) 22.63 $BDCL

BDC ETFs Under the Microscope - ETF News And Commentary
Sweta Killa - ZACKS - Tue Sep 16, 12:00PM CDT
Business Development Companies (BDC) ETFs could prove beneficial in the event of rising rates and strong economic growth.
ACAS: 14.32 (+0.03), ARCC: 15.93 (-0.04), BDCL: 22.63 (-0.17), BDCS: 23.53 (-0.09), BIZD: 18.91 (-0.10), PSEC: 9.64 (-0.03)

Leveraged ETF Round Up: MLP Funds March Higher, Gold Fades - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:00AM CDT
These leveraged and inverse ETFs led the way in the past week, with MLPs and natural gas bear funds surging.
GASL: 13.83 (+1.09), BDCL: 22.63 (-0.17), JNUG: 9.12 (+0.45), MLPL: 66.78 (+1.74), RUSS: 17.42 (+0.30), GASX: 23.42 (+0.02)

Time to Avoid Business Development Company ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jun 12, 2:00PM CDT
Should investors be worried about BDC ETFs in today's uncertain environment?
ACAS: 14.32 (+0.03), BDCL: 22.63 (-0.17), ARCC: 15.93 (-0.04), AINV: 8.00 (+0.01), BDCS: 23.53 (-0.09), BIZD: 18.91 (-0.10)

A Closer Look at Market Vectors' New BDC Income ETF - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu Feb 14, 4:35PM CST
Investors need to delve deep into this high income ETF to truly understand how it works.
ACAS: 14.32 (+0.03), BDCL: 22.63 (-0.17), ARCC: 15.93 (-0.04), BDCS: 23.53 (-0.09), BIZD: 18.91 (-0.10)

ETFdb Analyst Picks: Bull Run Holds For Now
Stoyan Bojinov - ETFDB - Fri Jan 04, 10:57AM CST
Santa came late this year but the fact that he showed up at all was good enough for investors on Wall Street. Policymakers in Washington D.C. managed to steer us away from the fiscal cliff, at least for now that is, as they struck a deal in virtually...
BDCL: 22.63 (-0.17), RSX: 20.97 (-0.10), XLU: 44.10 (+0.08), BTAL: 19.99 (+0.03)

Generate an Income Stream with Dividend ETFs
indogeniclegal@gmail.com (Sujata Dutta)via The Motley Fool - Motley Fool - Fri Dec 21, 2:30PM CST
Dividends are an important consideration for many investors, as they provide a steady stream of income and protect your portfolio from inflationary side effects. You can invest in stocks with high dividend yields, however, there is...
DON: 79.63 (+0.85), BDCL: 22.63 (-0.17), PEY: 12.66 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading